DL Life Logo June 7, 2013 - - - - 118,466 AMERICANS ARE CANDIDATES ON THE UNOS TRANSPLANT WAIT LIST DL Life Logo 96,868 waiting for a kidney DL Life Logo 15,776 wait-listed for a liver DL Life Logo 1,1865 waiting for a pancreasDL Life Logo 2,097 needing a Kidney-PancreasDL Life Logo 3,515 waiting for a life-saving heartDL Life Logo 1,662 waiting for a lungDL Life Logo 46 waiting for a heart-lungDL Life Logo 267 waiting for small bowelDL Life Logo One organ donor has the opportunity to save up to 8 lives DL Life Logo One tissue donor has the opportunity to save and -or enhance the lives of 50 or more individuals DL Life Logo You have the power to SAVE Lives by becoming an organ, eye and tissue donor, so what are you waiting for? To learn how to register click HEREDL Life Logo

Tuesday, June 19, 2012

New UCLA study reports which patients fare worse after heart transplantation

Emax Health | Robin Wulffson MD
According to UCLA cardiologists, heart transplant patients are very prone to developing an aggressive form of coronary artery disease, which often results in heart failure, death, or the need for repeat transplantation.

Furthermore, the condition may have a negative impact on future cardiac procedures, such as stenting. UCLA researchers have determined which heart transplant patients are prone to have poor long-term survival. Their study, one of the largest and longest follow-up studies of this patient population, was published in the June 15 edition of the American Journal of Cardiology.

The researchers note that transplant patients are among those at highest risk of adverse outcomes when receiving a stent to address a blockage in an artery. Compared with the general public, these patients have a much higher rate of restenosis, a side effect of stenting in which the artery becomes re-blocked because of an exaggerated scarring process at the stenting site. New research by UCLA researchers and colleagues has found that heart transplant patients who develop restenosis after receiving a stent have poor long-term survival.

No comments: